Kjell Elgjo

Kjell Elgjo's AcademicInfluence.com Rankings

Kjell Elgjo

Philosophy

#10638

World Rank

#14598

Historical Rank

Logic

#7510

World Rank

#9293

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Why Is Kjell Elgjo Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Kjell Elgjo was a Norwegian pathologist. He took the Candidate of Medicine degree at the University of Oslo in 1956 and the Doctor Medicinae degree in 1966. He was a prosector at the University of Oslo from 1965, docent from 1969 and professor from 1978 to his retirement in 1996. Since 1985 he was a fellow of the Norwegian Academy of Science and Letters.

(See a Problem?)

Kjell Elgjo's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Relationship of inflammatory bowel disease and primary sclerosing cholangitis. (1991) (274)
Primary sclerosing cholangitis: a long-term follow-up study. (1987) (264)
Sclerosing cholangitis in ulcerative colitis. (1980) (198)
Risk factors in primary sclerosing cholangitis. (1994) (132)
The Vertebrate Epidermal Chalone (1967) (124)
Change in the extent of colonoscopic and histological involvement in ulcerative colitis over time (1999) (114)
Comparison of two-stage epidermal carcinogenesis initiated by 7,12-dimethylbenz(a)anthracene or N-methyl-N'-nitro-N-nitrosoguanidine in newborn and adult SENCAR and BALB/c mice. (1981) (114)
CIRCADIAN RHYTHMS IN MOUSE EPIDERMAL BASAL CELL PROLIFERATION (1979) (113)
Hepatic lesions in adult coeliac disease. (1990) (110)
Stimulated DNA synthesis in mouse epidermal cell cultures treated with 12-O-tetradecanoyl-phorbol-13-acetate. (1976) (105)
Sclerosing cholangitis in ulcerative colitis. A follow-up study. (1982) (103)
EPIDERMAL REGENERATION AFTER CELLOPHANE TAPE STRIPPING OF HAIRLESS MOUSE SKIN (1970) (94)
Specific and nonspecific humoral defense factors in the epithelium of normal and inflamed gastric mucosa. Immunohistochemical localization of immunoglobulins, secretory component, lysozyme, and lactoferrin. (1984) (86)
NEONATAL CHOLESTASIS IN ALPHA‐1‐ANTITRYPSIN DEFICIENT CHILDREN Clinical, Genetic, Histological and Immunohistochemical Findings (1972) (83)
Large-bowel carcinomas with different ploidy, related to secretory component, IgA, and CEA in epithelium and plasma. (1982) (80)
Factors of prognostic importance in primary biliary cirrhosis. (1990) (73)
Hepatobiliary complications of inflammatory bowel disease. (1988) (66)
Delayed inhibition of epidermal DNA synthesis after injection of an aqueous skin extract (Chalone) (1969) (66)
Serum proteins in diseases of the liver. (1975) (59)
Hepatic adenyl cyclase: alterations in hormone response during treatment with a chemical carcinogen. (1972) (57)
Plasma carcinoembryonic antigen concentrations and immunohistochemical patterns of epithelial marker antigens in patients with large bowel carcinoma. (1982) (56)
Hepatobiliary disease in ulcerative colitis. An analysis of 18 patients with hepatobiliary lesions classified as small-duct primary sclerosing cholangitis. (1994) (52)
Neuronal cell death in the visual cortex is a prominent feature of the X-linked recessive mitochondrial deafness-dystonia syndrome caused by mutations in the TIMM8a gene (2001) (49)
Quantitative distribution of immunoglobulin-producing cells in gastric mucosa: relation to chronic gastritis and glandular atrophy. (1986) (48)
Immunohistochemical study of secretory component, secretory IgA and carcinoembryonic antigen in large bowel carcinomas. (1980) (47)
Purification and characterization of a mitosis inhibiting epidermal peptide. (1984) (46)
Immunohistochemical evaluation of carcinoembryonic antigen, secretory component, and epithelial IgA in ulcerative colitis with dysplasia. (1982) (45)
Purified epidermal pentapeptide inhibits proliferation and enhances terminal differentiation in cultured mouse epidermal cells. (1986) (45)
Retinyl acetate modulation of cell growth kinetics and carcinogen--cellular interaction in mouse epidermal cell cultures. (1977) (44)
Eccrine angiomatous hamartoma of the finger leading to amputation (1991) (43)
Lipoprotein-X (LP-X) in liver disease. (1973) (43)
Epidermal cell population kinetics after a single application of some hyperplasia-producing substances. (1968) (43)
Sulfonamide-induced chronic liver disease. (1974) (43)
The effect of an epidermis-specific mitotic inhibitor (chalone) extracted from epidermal cells. (1965) (43)
Isolation and structure of an epidermal mitosis inhibiting pentapeptide. (1987) (39)
Amyloidosis and Crohn's disease. (1977) (39)
Natural synchrony of newborn mouse epidermal cells in vitro. (1976) (38)
Adrenaline increases cyclic 3'5'-AMP formation in hamster epidermis. (1971) (36)
DNA synthesis in mouse epidermis: S phase cells that remain unlabeled after pulse labeling with DNA precursors progress slowly through S. (1983) (36)
Change in the extent of colonoscopic and histological involvement in ulcerative colitis over time. (1999) (35)
Growth regulation in mouse epidermis (1971) (33)
Chalones – From Aqueous Extracts To Oligopeptides (2004) (33)
Pathology and pathogenesis of liver disease in alpha-1-antitrypsin deficient individuals. (1974) (32)
Effects of tumor promoters and steroidal anti-inflammatory agents on skin of newborn mice in vivo and in vitro. (1978) (32)
UVB-induced epidermal hyperproliferation is modified by a single, topical treatment with a mitosis inhibitory epidermal pentapeptide. (1990) (32)
Growth regulation in mouse epidermis (1972) (31)
Malignant conversion and metastasis of mouse skin tumors: a comparison of SENCAR and CD-1 mice. (1986) (29)
Cell renewal of the normal mouse cornea. (2009) (29)
Immunohistochemical characterization of hepatic tissue lymphocyte subpopulations in liver disease. (1982) (29)
The epidermal pentapeptide pyroGlu-Glu-Asp-Ser-GlyOH inhibits murine hair growth in vivo and in vitro. (1991) (28)
Intractable watery diarrhoea, hypokalaemia, and achlorhydria associated with non-pancreatic retroperitoneal neurogenous tumour containing vasoactive intestinal peptide (V.I.P.). (1973) (28)
Epidermal chalone and cyclic AMP: an in vivo study. (1975) (27)
Epidermal growth inhibitors (Chalones) in dermis and serum (1973) (24)
Interferon-alpha 2b therapy in low-activity hepatitis C: a pilot study. (1997) (24)
Heterogeneous epithelial expression of class II (HLA-DR) determinants and secretory component related to dysplasia in ulcerative colitis. (1987) (23)
Epidermal mitotic rate and DNA synthesis after injection of water extracts made from mouse skin treated with actinomycin D: Two or more growth-regulating substances? (1971) (23)
Chalone inhibition of cellular proliferation. (1972) (22)
Hydrocortisone: Inhibition of DNA synthesis and mitotic rate after local application to mouse epidermis (1971) (22)
Crohn's disease. Clinical manifestations. (1985) (22)
Classification of liver diseases by clinical chemical laboratory results and cluster analysis. (1976) (21)
Intractable watery diarrhoea, hypokalaemia, and achlorhydria associated with pancreatic tumour containing gastric secretory inhibitor. (1970) (19)
Epidermal chalone and cell proliferation in a transplantable squamous cell carcinoma in hamsters (1971) (19)
Synthetic epidermal pentapeptide and related growth regulatory peptides inhibit proliferation and enhance differentiation in primary and regenerating cultures of human epidermal keratinocytes. (1990) (18)
Epidermal cell proliferation during the first 24 hr after injection of an aqueous skin extract (Chalone) (1969) (18)
Epidermis Extracts (Chalone) Inhibit Cell Flux At the G1‐S, S‐G2 and G2‐M Transitions In Mouse Epidermis (1981) (18)
Growth regulation in mouse epidermis. I. G 2 -inhibitor present in the basal cell layer. (1971) (18)
Skin biopsies for early diagnosis and prognosis of graft-versus-host disease in recipients of allogeneic stem cells from blood or bone marrow (2004) (17)
The significance of anti-hepatitis C virus antibodies measured in chronic liver disease. (1991) (17)
Quantification of gastrin-producing cells (G cells) and parietal cells in relation to histopathological alterations in resected stomachs from patients with peptic ulcer disease. (1978) (17)
Biochemical tests in evaluation of liver function. (1973) (16)
Liver steatosis in hypobetalipoproteinemia. A case report. (1991) (16)
Liver disease in anti-hepatitis C virus-positive Norwegian blood donors. (1994) (15)
Laxative-induced chronic liver disease. (1972) (15)
Pentapeptide inhibitor of epidermal mitosis: production and responsiveness in cultures of normal, transformed and neoplastic human keratinocytes. (1989) (15)
Congenital hypochromic microcytic anaemia with iron overload of the liver and hyperferraemia. (2009) (15)
Distribution of dysplasia in ulcerative colitis. (1984) (15)
Circulating secretory immunoglobulins of the A and M isotypes in chronic liver disease. (1987) (14)
Detection of immunoglobulins in paraffin-embedded liver biopsies. Studies in 100 patients with special regard to immunological findings in active chronic hepatitis. (1973) (14)
A class of DNA-binding peptides from wheat bud causes growth inhibition, G2 cell cycle arrest and apoptosis induction in HeLa cells (2009) (14)
The tumorigenic and carcinogenic effect of TPA (12-0-tetradecanoylphorbol-13-acetate) when applied to the skin of BALB/cA mice. (1980) (14)
Partial purification of epidermal G2 chalone (1977) (14)
Growth regulation in mouse epidermis. II. G 1 -inhibitor present in the differentiating cell layer. (1972) (13)
Diagnostic and prognostic value of laboratory tests assessed in a follow-up study of 200 patients with liver disease. (1982) (13)
An endogenous melanocyte‐inhibiting tripeptide pyroGlu‐Phe‐GlyNH2 delays in vivo growth of monoclonal experimental melanoma (2000) (13)
Identification of a melanocyte growth-inhibiting tripeptide and determination of its structure. (2009) (12)
Effects of methylcholanthrene on epidermal growth regulators. I. Variations in the M-factor. (1972) (11)
Enhancement of methylnitrosourea-induced skin tumorigenesis and carcinogenesis in hairless mice by pretreatment with a mitosis-inhibiting epidermal pentapeptide. (1989) (11)
Reversible inhibition of epidermal G-l cells by repeated injections of aqueous skin extracts (chalone) (1974) (11)
Liver copper content in patients with inflammatory bowel disease and associated liver disorders. (1979) (11)
The stability of the epidermal mitosis inhibiting factor (chalone) in water solution. (2009) (11)
Dna Synthesis Rate Changes During the S Phase In Mouse Epidermis (1985) (10)
Bacteria of the gastric antrum and their relation to chronic gastritis (1988) (10)
Beta-receptor blockade by propranolol modifies the effect of the inhibitory, endogenous epidermal pentapeptide on epidermal cell flux at the G2-M transition but not at the G1-S transition. (1994) (10)
Cholangiographic Findings in Ulcerative Colitis (1981) (10)
Growth-inhibiting N-substituted endogenous peptides. (1998) (10)
The colon mitosis-inhibitor pyroglutamyl-histidyl-glycine alters expression of immediate-early cancer-related genes in HT-29 cells. (2003) (9)
Diagnostic utility of the polymerase chain reaction in 2 cases of suspected Whipple disease. (1998) (9)
Alterations in epidermal growth kinetics induced by coal tar ointment and methotrexate. (1973) (9)
Monstrous ascites in hereditary haemorrhagic telangiectasia. (1995) (9)
The synthetic hepatic peptides pyroglutamylglutamylglycylserylasparagine and pyroglutamylglutamylglycylserylaspartic acid inhibit growth of MH1C1 rat hepatoma cells transplanted into Buffalo rats or athymic mice. (1992) (9)
Measurement of enzyme activity in colonic biopsies: a test for premalignancy in ulcerative colitis? (1984) (8)
Epidermal chalone and cell proliferation in a transplantable squamous cell carcinoma in hamsters (1971) (8)
Crohn's disease. Diagnostic procedures and problems. (1985) (8)
Novel lymphocyte growth-inhibiting tripeptide: N-acetyl-glu-ser-GlyNH(2). (2000) (8)
Evidence for presence of the epidermal G2-inhibitor (“epidermal chalone”) in dermis (1974) (7)
The peptide pyroGlu-Gln-Gly-Ser-Asn, isolated from mouse liver, inhibits growth of rat hepatoma cells in vitro. (1991) (7)
The effects of a growth-inhibiting tripeptide, acetylGlu-Ser-GlyNH2 (Ac-ESG), on gene expression and cell cycle progression of two lymphoma cell lines. (2003) (6)
Enzyme activity and protein patterns as premalignant markers in mucosal biopsy specimens from the large intestine. (1985) (6)
Partial purification of the epidermal G2 chalone based on an in vivo assay system. (1981) (6)
Pentapeptide Growth Inhibitors (1990) (6)
Dimethyl nitrosamine-induced proliferative and neoplastic lesions in the mouse liver characterized by histopathology and flow cytometric DNA measurements. (2009) (6)
Growth kinetics of the mouse epidermis after a single application of cigarette smoke condensates. (2009) (6)
Growth kinetics of the mouse epidermis after a single application of 3,4-benzopyrene, croton oil, or 1,2-benzopyrene. (2009) (5)
The significance of anti-HCV antibodies Measured in chronic liver disease (1990) (5)
Mouse epidermal cell proliferation after a single application of dimethyl sulphoxide (DMSO). (1983) (5)
Antiproliferative effect of the tripeptide pyroGlu-Phe-GlyNH2 on murine melanocytes: transitory delay of cell growth in vitro and the cell cycle specificity. (1998) (5)
Effects of croton oil on epidermal growth regulators (chalones). (1976) (5)
Local immunoglobulin production is different in gastritis associated with dermatitis herpetiformis and simple gastritis. (1987) (5)
Peroperative endoscopic diagnosis of small intestinal bleeding. (1978) (5)
Relative value of sternal aspiration, iliac crest biopsy and biopsy imprint in the diagnosis of secondary cancer involvement of the bone marrow. (2009) (5)
Duration and Rate of Mitosis after a Single Application of Methylcholanthrene (1963) (5)
Pyroglutamyl-histidyl-glycine, the endogenous colon mitosis inhibitor, regulates cyclic AMP level in non-tumorigenic colonic epithelial cells. (2004) (5)
S-Alkylglutathione, methylglyoxal metabolism and cell division. (1970) (5)
[Primary sclerosing cholangitis and inflammatory bowel disease]. (1990) (4)
Regeneration of rat corneal epithelium is delayed by the inhibitory epidermal pentapeptide (EPP). (2009) (4)
Methylcholanthrene-induced skin carcinogenesis modified by treatment with polyinosinic:polycytidylic acid (poly I:C). (1971) (4)
Inhibitory epidermal pentapeptide modulates proliferation and differentiation of transformed mouse epidermal cells in vitro (1991) (4)
Growth regulation in X-irradiated mouse skin; the possible role of chalones. (1978) (4)
Epidermal proliferation characteristics are similar in the pilary canal of mouse hair follicles and in interfollicular epidermis (1982) (4)
The colon mitosis inhibitor pyroglutamyl-histidyl-glycine inhibits growth of non-tumorigenic colonic epithelial cells. (2004) (4)
Difference in the distribution of low-molecular-weight peptides and amino-acids in normal and malignant-cells and tissues. (1994) (4)
Could development of malignant mesothelioma be induced by Yersinia enterocolitica infection? (1993) (4)
Epidermal cell population kinetics after repeated applications of some hyperplasia-producing substances. (1968) (3)
Polyinosinic-polycytidylic acid: inhibition of cell proliferation in carcinogen-treated epidermis and in carcinogen-induced skin tumors in mice. (1975) (3)
Endogenous tetrapeptide from neuroblastoma and new-born pig brain inhibits neuroblastoma cell growth in vitro. (2002) (3)
METASTASIS TO THE CHAMBER ANGLE FROM MUCOID BREAST CARCINOMA (1964) (3)
Effects of methylcholanthrene on epidermal growth regulators. II. Variations in the S-factor. (1976) (3)
[Natural products can be hazardous to health]. (1992) (3)
Postoperative jaundice in patients undergoing cardiac surgery. An incomplete cholestatic syndrome of multifactorial etiology. (1987) (3)
Local immune defence in relation to gastritis in Billroth-II-resected stomachs. (1988) (2)
Influence of synthetic polynucleotides and interferon on in vitro growth of cells derived from a mouse sarcoma. (1974) (2)
CELL POPULATION KINETICS IN MOUSE EPIDERMIS AFTER REPEATED APPLICATIONS OF 20-METHYLCHOLANTHRENE. (1965) (2)
Chronic active hepatitis. Experience from a Norwegian reference hospital during a decade. (1985) (2)
Moderate enhancement of the promotion phase of skin tumorigenesis in hairless mice by topical pretreatment with a mitosis-inhibiting epidermal pentapeptide. (1993) (2)
Is there a final common path in malignancies? (2013) (2)
Uveal melanomas with optic nerve extension: report of two cases diagnosed by transvitreal biopsy, one of them with a multicentric tumour. (2001) (2)
Effect of tumour size on the in vivo growth inhibition of human colon carcinoma cells (HT-29) by colon mitosis inhibitor. (2001) (2)
Lactate dehydrogenase isoenzymes in mucosal biopsy specimens from patients with ulcerative colitis. (1985) (2)
EFFECTS OF BLEOMYCIN ON THE EPIDERMAL CONTENT OF GROWTH‐REGULATORY SUBSTANCES (CHALONES) (1977) (2)
Solitary plasmocytoma of the spleen with marked polyclonal increase of gamma G, normalized after splenectomy. (2009) (1)
Morphology of mouse epidermal cells in vitro: a scanning electron microscopy study. (1977) (1)
Incorporation of precursors into sterols and proteins in liver biopsies from patients with liver disorders. (1984) (1)
Modulation of KB and A431 cell adhesion by epidermal growth inhibitory pentapeptide (1992) (1)
Adenomyomatosis of the gallbladder. Report of a case. (1971) (1)
Altered growth kinetics precede calcium-induced differentiation in mouse epidermal cells (1986) (1)
Zinc and the mitosis-inhibitory epidermal pentapeptide (EPP) form a stimulatory chelated dimer (2005) (1)
Kinetics of Cellular Growth after Repeated Applications of Methylcholanthrene (1965) (1)
25 Epidermal Growth Inhibitors (Chalones) Show Circadian Stage Dependent Effects on Cell Cycle Progression in Mice (1984) (1)
Growth parameters of the hairless mouse epidermis after bleomycin treatment: possible interaction with epidermal chalones. (1976) (0)
Loss of protein from stomach and intestine. (1961) (0)
INTRASPINAL HEMORRHAGES IN NEWBORNS (2009) (0)
[Chronic hepatitis]. (1972) (0)
[Computer tomography of fatty liver]. (1981) (0)
[Primary liver cancer. Diagnosis, therapy and prognosis]. (1984) (0)
[Computerized tomography of the pancreas]. (1980) (0)
[Intrahepatic cholestasis in lymphogranulomatosis]. (1978) (0)
Selective detachment of a tetraploid subline of primary keratinocytes after treatment with the tumor promoter 12-0-tetradecanoylphorbol-13-acetate. (1988) (0)
Supplement II: Abstracts of the international symposium on Skin Carcinogenesis in man and in experimental models. Heidelberg, 29–31 October 1991 (pp S61–S88) (1991) (0)
[Protein loss from the stomach and intestines]. (1961) (0)
SMALL PEPTIDES MAY BE TISSUE SPECIFIC MITOSIS INHIBITORS INDUCING TERMINAL DIFFERENTIATION (1987) (0)
Pentapeptider with a cellvaextreglerande effekt a Science foerfarande Foer framstaellning thereofThe. (1987) (0)
[Nitrosamines--a new group of carcinogens]. (1967) (0)
Follow-up and prospective studies of the classification of liver disease. (1985) (0)
[Chronic non-A non-B hepatitis treated with interferon]. (1990) (0)
Biologically active pyroglutamyl N-terminal oligopeptides: parts of larger molecules? (1995) (0)
[A case of autonomic dysfunction after acute anterior poliomyelitis]. (1960) (0)
[Cellular and vascular elements and the connective tissue reaction in inflammation]. (1972) (0)
Immunohistochemical evaluation ofcarcinoembryonic antigen, secretory component, andepithelial IgAin ulcerative colitis withdysplasia* (1982) (0)
Novel growth inhibitory peptides for melanocytes and neuroblastoma cells: 317 (1997) (0)
[Cardiopulmonary failure in adipositas "The Pickwickian syndrome"]. (1960) (0)

This paper list is powered by the following services:

Other Resources About Kjell Elgjo

en.wikipedia.org

What Schools Are Affiliated With Kjell Elgjo?

Kjell Elgjo is affiliated with the following schools:

University of Oslo